Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07298902 · ClinicalTrials.gov registry record · NA
Non-Invasive Deep Brain Neuromodulation for Smoking Cessation
A NA study, sponsored by The University of Texas Health Science Center, Houston.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT07298902 is a NA study that is actively recruiting participants, run by The University of Texas Health Science Center, Houston. The registered enrollment target is 100 participants.
The verdict
NCT07298902, a NA study, is actively recruiting participants, sponsored by The University of Texas Health Science Center, Houston.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study will develop novel low intensity focused ultrasound (LIFU) therapy to help people to quit cigarette smoking. Smoking is associated with cancers of the lung. Available smoking cessation methods help many to quit. However, for the many who continue to smoke despite the strong desire to quit and after exhausting existing therapeutic approaches, new treatment methods are needed. Without more effective treatment, many will continue to smoke, and our progress on cancer prevention through smoking cessation may decelerate as these associated cancer risks will remain. Brain imaging research has identified specific areas of the brain linked to severe nicotine addiction, but up to now there are no effective ways to directly target most of these deeper brain regions. LIFU is a new and safe method to modulate brain functions that can either inhibit overactive activity or restore normal activity levels. The purpose of this study is to provide a novel ultrasound-based neuromodulation strategy for smoking cessation in people who have difficulty to quit smoking despite numerous serious attempts in their lives. LIFU works by sending acoustic pressure modulating neural activity in the human brain.
Interventions
- DEVICE Low intensity focused ultrasound with active stimulations
- DEVICE low intensity focused ultrasound with sham stimulations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2026-04-13 |
| Est. Completion | 2030-11-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07298902
The ClinicalTrials.gov registry entry for NCT07298902 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The University of Texas Health Science Center, Houston, which has 732 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Low intensity focused ultrasound with active stimulations is the first listed.
NCT07298902 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07298902 about?
NCT07298902 is a clinical study titled "Non-Invasive Deep Brain Neuromodulation for Smoking Cessation". This study will develop novel low intensity focused ultrasound (LIFU) therapy to help people to quit cigarette smoking. Smoking is associated with cancers of the lung. Available smoking cessation methods help many to quit. However, for the many who continue to smoke despite the strong desire to quit...
What is the current status of trial NCT07298902?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2026-04-13. Estimated completion is 2030-11-30.
What interventions are being tested in trial NCT07298902?
The interventions under investigation include: Low intensity focused ultrasound with active stimulations (DEVICE), low intensity focused ultrasound with sham stimulations (DEVICE).
Who is sponsoring clinical trial NCT07298902?
This trial is sponsored by The University of Texas Health Science Center, Houston, which has 732 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.